Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome
- PMID:29037509
- DOI: 10.1016/j.toxlet.2017.10.012
Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome
Abstract
The eosinophilia-myalgia syndrome (EMS) outbreak of 1989 that occurred in the USA and elsewhere was caused by the ingestion of l-Tryptophan (L-Trp) solely manufactured by the Japanese company Showa Denko K.K. (SD). Six compounds present in the SD L-Trp were reported to be case-associated contaminants. However, "one" of these compounds, Peak AAA has remained structurally uncharacterized, despite the fact that it was described as "the only statistically significant (p=0.0014) contaminant". Here, we employ on-line microcapillary-high performance liquid chromatography-electrospray ionization mass spectrometry (LC-MS), and tandem mass spectrometry (MS/MS) to determine that Peak AAA is in fact two structurally related isomers. Peak AAA1 and Peak AAA2 differed in LC retention times, and were determined by accurate mass-LC-MS to both have a protonated molecular ion (MH+) of mass 343.239Da (Da), corresponding to a molecular formula of C21H30N2O2, and possessing eight degrees of unsaturation (DoU) for the non-protonated molecule. By comparing the LC-MS and LC-MS-MS retention times and spectra with authentic synthetic standards, Peak AAA1 was identified as the intermolecular condensation product of L-Trp with anteiso 7-methylnonanoic acid, to afford (S)-2-amino-3-(2-((S,E)-7-methylnon-1-en-1-yl)-1H-indol-3-yl)propanoic acid. Peak AAA2 was determined to be a condensation product of L-Trp with decanoic acid, which produced (S)-2-amino-3-(2-((E)-dec-1-en-1-yl)-1H-indol-3-yl)propanoic acid.
Keywords: Case-associated; Contaminants; Dietary supplements; Eosinophilia myalgia syndrome; Peak AAA.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
- Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome.Klarskov K, Gagnon H, Racine M, Boudreault PL, Normandin C, Marsault E, Gleich GJ, Naylor S.Klarskov K, et al.Toxicol Lett. 2018 Sep 15;294:193-204. doi: 10.1016/j.toxlet.2018.05.027. Epub 2018 May 22.Toxicol Lett. 2018.PMID:29800716
- On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome.Williamson BL, Johnson KL, Tomlinson AJ, Gleich GJ, Naylor S.Williamson BL, et al.Toxicol Lett. 1998 Oct 15;99(2):139-50. doi: 10.1016/s0378-4274(98)00223-9.Toxicol Lett. 1998.PMID:9817085
- Structural characterization of case-associated contaminants peak C and FF in L-tryptophan implicated in eosinophilia-myalgia syndrome.Naylor S, Williamson BL, Johnson KL, Gleich GJ.Naylor S, et al.Adv Exp Med Biol. 1999;467:453-60. doi: 10.1007/978-1-4615-4709-9_57.Adv Exp Med Biol. 1999.PMID:10721088
- Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.Kilbourne EM, Philen RM, Kamb ML, Falk H.Kilbourne EM, et al.J Rheumatol Suppl. 1996 Oct;46:81-8; discussion 89-91.J Rheumatol Suppl. 1996.PMID:8895184Review.
- L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.Varga J, Jimenez SA, Uitto J.Varga J, et al.J Invest Dermatol. 1993 Jan;100(1):97S-105S. doi: 10.1111/1523-1747.ep12356368.J Invest Dermatol. 1993.PMID:8423409Review.
Cited by
- 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.Maffei ME.Maffei ME.Int J Mol Sci. 2020 Dec 26;22(1):181. doi: 10.3390/ijms22010181.Int J Mol Sci. 2020.PMID:33375373Free PMC article.Review.
- Simultaneous determination of L-tryptophan impurities in meat products.Lee DH, Kim YH, Baek M, Heo IK, Shin Y.Lee DH, et al.Amino Acids. 2023 Feb;55(2):173-182. doi: 10.1007/s00726-022-03215-8. Epub 2023 Jan 2.Amino Acids. 2023.PMID:36588144Free PMC article.
- Comprehensive review of melatonin as a promising nutritional and nutraceutical supplement.Kamfar WW, Khraiwesh HM, Ibrahim MO, Qadhi AH, Azhar WF, Ghafouri KJ, Alhussain MH, Aldairi AF, AlShahrani AM, Alghannam AF, Abdulal RH, Al-Slaihat AH, Qutob MS, Elrggal ME, Ghaith MM, Azzeh FS.Kamfar WW, et al.Heliyon. 2024 Jan 8;10(2):e24266. doi: 10.1016/j.heliyon.2024.e24266. eCollection 2024 Jan 30.Heliyon. 2024.PMID:38293391Free PMC article.Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials